Giorgia Iegiani
- 502210
- Phd: 36th cycle
- Department of Neurosciences "Rita Levi Montalcini"
- Matriculation number: 817423
- ORCID: orcid.org/0000-0003-2966-9675
Contacts
- giorgia.iegiani@unito.it
- Neuroscience Institute Cavalieri Ottolenghi (NICO)
Regione Gonzole 10, 10043 Orbassano (Turin), Italy - https://phd-csqb.campusnet.unito.it/do/studenti.pl/Show?817423
- VCard contacts
- QRcode contacts
Supervisor
Ferdinando Di CuntoResearch activities
- Iegiani, G., Di Cunto, F. & Pallavicini, G. Inhibiting microcephaly genes as alternative to microtubule targeting agents to treat brain tumors. Cell Death Dis 12, 956 (2021). https://doi.org/10.1038/s41419-021-04259-6
- Gianmarco Pallavicini, Marta Gai, Giorgia Iegiani, Gaia Elena Berto, Annie Adrait, Yohann Couté, Ferdinando Di Cunto; Goldberg–Shprintzen syndrome protein KIF1BP is a CITK interactor implicated in cytokinesis. J Cell Sci 1 June 2021; 134 (11): jcs250902. doi: https://doi-org/10.1242/jcs.250902
- Iegiani, G.; Gai, M.; Di Cunto, F.; Pallavicini, G. CENPE Inhibition Leads to Mitotic Catastrophe and DNA Damage in Medulloblastoma Cells. Cancers 2021, 13, 1028. https://doi.org/10.3390/cancers13051028
Pallavicini G., Iegiani G., Berto G. E., Calamia E., Trevisiol E., Veltri A., Allis S., Di Cunto F. (2020). CITK loss inhibits growth of group 3 and group 4 medulloblastoma cells and sensitizes them to DNA-damaging agents. CANCERS, vol. 12, p. 1-18, ISSN: 2072-6694, https://doi.org/10.3390/cancers12030542
Rackov G, Iegiani G, Uribe D, Quezada C, Belda-Iniesta C, Escobedo-Lucea C, Silva A, Puig P, Gonzalez-Rumayor V, Ayuso-Sacido A (2020). Potential Therapeutic Effects of the Neural Stem Cell-Targeting Antibody Nilo1 in Patient-Derived Glioblastoma Stem Cells. FRONTIERS IN ONCOLOGY, vol. 10, ISSN: 2234-943X, https://doi.org/10.3389/fonc.2020.01665